FDA Warns Online Pharmacies

January 2010
Pharmaceutical Representative;Jan2010, Vol. 40 Issue 1, p11
The article reports on the issuance of letters by the Food and Drug Administration (FDA) to operators of online pharmacies to warn them against illegal drug sales online in the U.S.


Related Articles

  • Toxic herb sold via the Internet.  // Better Nutrition;Jan2004, Vol. 66 Issue 1, p22 

    The article reports that many Web sites are marketing products known, or suspected, to contain aristolochic acid — a potent chemical that has been banned for years in Canada and Great Britain and can cause cancer and kidney failure. A recent study published in the October 16, 2003 edition...

  • FDA cautions consumers on Ebola web promotions. Dickinson, James G. // Medical Marketing & Media;Oct2014, Vol. 49 Issue 10, p16 

    The article reports that the U.S. Food and Drug Administration (FDA) has warned consumers against products sold online that claims to prevent or treat Ebola virus infections.

  • Speakers recommend new FDA regulations for promoting drugs and devices online.  // Infectious Diseases in Children;Dec2009, Vol. 22 Issue 12, p38 

    The article focuses on new U.S. Food and Drug Administration (FDA) regulations for promoting drugs and devices online recommended by speakers at the FDA meeting held in 2009.

  • As I See It. Friede, Arnie // Medical Marketing & Media;Jun2011, Vol. 46 Issue 6, p28 

    The article offers the author's insights which criticize the various Federal Register Notice guidelines of the U.S. Food and Drug Administration (FDA) for direct-to-consumer (DTC) prescription drug websites such as the opposition to the potential use of hyperlinks to provide risk information and...

  • TENS promoted for surgical analgesia.  // Medical Device Daily;10/19/2009, Vol. 13 Issue 201, p6 

    The article reports on a warning letter sent by the U.S. Food and Drug Administration (FDA) to Pantheon Research which states that the agency's review of Pantheon's web site disclosed that the firm was marketing several models of electro-stimulation products outside of cleared indications, like...

  • FDA Actions. Elliott, William T. // Infectious Disease Alert;Aug2008, Vol. 27 Issue 11, p2 

    The article reports on the actions made by the U.S. Food and Drug Administration (FDA). The agency has approved a new pentavalent vaccine for 6-week to 4-year-old children which is being marketed by Sanofi Pasteur and combines diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus...

  • Drug marketing and the new media. Webb, Sarah // Nature Biotechnology;May2010, Vol. 28 Issue 5, p396 

    The article discusses the legal and regulatory issues faced by transitioning medical communication and marketing campaigns to the Internet. It highlights the role of social media as a new way for drug companies to interact with consumers. It explores the challenges posed by controlling the flow...

  • Principles in Action: An Examination of Food and Drug Administration Letters Involving Violative Internet Promotions from 1997 to 2012. Hoy, Mariea Grubbs; Park, Jin Seong // Journal of Public Policy & Marketing;Fall2014, Vol. 33 Issue 2, p127 

    Given the increasing importance of the Internet as a platform for pharmaceutical marketing, drug companies have called for guidance from the Food and Drug Administration (FDA). Of key concern is how marketers can fulfill the fair balance requirement within the space constraints of most social...

  • Can FDA manage to stay above the fray? Dickinson, James G. // Medical Marketing & Media;Dec2013, Vol. 48 Issue 12, p34 

    The article reports on the plan of the U.S. Food and Drug Administration (FDA) to issue guidance that depicts its policy on Internet promotion. According to the FDA, it will release guidance on methodologies for assessing a Risk Evaluation and Mitigation Strategy of a drug, which includes a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics